These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15628441)

  • 1. [Prolyl hydroxylase (PH)].
    Yamada S; Kawasaki H
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():445-7. PubMed ID: 15628441
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolyl hydroxylase (PH)].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1999 Aug; 57 Suppl():422-4. PubMed ID: 10503460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolyl hydroxylase].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():383-5. PubMed ID: 8753452
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer.
    Bolarin DM
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 6. Human prolyl-hydroxylase: only a marker of hepatic damage?
    Tamaro G; Pozzato G; Moretti M
    Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum prolyl hydroxylase protein in experimental liver cancer.
    Bolarin DM
    Acta Physiol Hung; 1988; 71(1):55-9. PubMed ID: 2839006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum prolyl hydroxylase in diabetic microangiopathy].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():126-8. PubMed ID: 9513402
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of serum prolyl hydroxylase analysis in the diagnosis of diabetic diseases].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1990 Dec; 48 Suppl():370-3. PubMed ID: 1964975
    [No Abstract]   [Full Text] [Related]  

  • 10. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase activity in liver and serum of rats and human subjects intoxicated by chronic administration of ethanol.
    Pawlicka E; Bańkowski E; Pałka J; Markiewicz W
    Hepatogastroenterology; 1987 Dec; 34(6):243-5. PubMed ID: 2828207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?
    Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoreactive prolyl 4-hydroxylase as a specific marker of hepatocellular necrosis.
    Nagai Y; Toda G
    Clin Chim Acta; 1990 Sep; 190(1-2):109-10. PubMed ID: 2170064
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum prolyl hydroxylase values in liver diseases].
    Miyabayashi C; Inoue K; Takahara T; Matsui S; Kojima T; Sasaki H; Ooshima A; Iwata K; Yoshida S
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2181-9. PubMed ID: 3029473
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum and tissue prolyl hydroxylase (PH) in hepatocellular carcinoma and gastrointestinal cancer].
    Suzuki M; Suzuki H; Kato Y; Okabe K; Uchikoshi T; Okazaki N
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2232-8. PubMed ID: 2850377
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate therapy and liver fibrosis: are human prolyl hydroxylase and type IV collagen reliable and sensitive markers?
    Tamaro G; Danek GM; Mangiarotti MA; Tamaro P; Zanazzo GA
    Int J Clin Lab Res; 1995; 25(1):55. PubMed ID: 7787212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.